Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects

Prostaglandins and Other Lipid Mediators

Volumn 87, Issue 1-4, 2008, Pages 1-8

  Konger, Raymond L ^a   Marathe, Gopal K ^b   Yao, Yongxue ^a,c   Zhang, Qiwei ^a,c   Travers, Jeffrey B ^a,c,d  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF MYSORE   (India)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Glycerophosphoscholines; Oxidation; Peroxisome proliferator activated receptor gamma; Platelet activating factor receptor; Ultraviolet rays

Indexed keywords

CYCLOOXYGENASE 2; GLYCEROPHOSPHORYLCHOLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LINOLEIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ATHEROGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN KB; CYTOKINE PRODUCTION; CYTOTOXICITY; DELAYED HYPERSENSITIVITY; GENE EXPRESSION; HUMAN; INNATE IMMUNITY; KERATINOCYTE; NONHUMAN; OXIDATIVE STRESS; PHOTOOXIDATION; PSORIASIS; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION;

ANIMALS; HUMANS; KERATINOCYTES; OXIDATION-REDUCTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHOSPHATIDYLCHOLINES; PLATELET ACTIVATING FACTOR; ULTRAVIOLET RAYS;

EID: 55549101910     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2008.04.002     Document Type: Short Survey

References (101)

1. Hussein M.R. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutaneous Pathol 32 3 (2005) 191-205
2. Nishigori C. Cellular aspects of photocarcinogenesis. Photochem Photobiol Sci 5 2 (2006) 208-214
3. Sesto A., Navarro M., Burslem F., and Jorcano J.L. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA (2002) 052678999
4. Enk C.D., Jacob-Hirsch J., Gal H., et al. The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene 25 18 (2006) 2601-2614
5. Ullrich S.E. Sunlight and skin cancer: lessons from the immune system. Mol Carcinogen 46 8 (2007) 629-633
6. Gardner H.W. Oxygen radical chemistry of polyunsaturated fatty acids. Free Rad Biol Med 7 1 (1989) 65-86
7. Galle J., Hansen-Hagge T., Wanner C., and Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185 2 (2006) 219-226
8. Nicholson A.C., and Hajjar D.P. CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis. Vascular Pharmacol 41 4/5 (2004) 139-146
9. Travers J.B., Harrison K.A., Johnson C.A., Clay K.L., and Morelli J.G. Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes. J Invest Dermatol 107 1 (1996) 88-94
10. Frankel E.N. Chemistry of free radical and singlet oxidation of lipids. Prog Lipid Res 23 4 (1984) 197-221
11. Marathe G.K., Johnson C., Billings S.D., et al. Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. J Biol Chem 280 42 (2005) 35448-35457
12. Zhang Q., Southall M.D., Mezsick S.M., et al. Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiation. J Biol Chem 280 1 (2005) 73-79
13. Ishii S., Nagase T., and Shimizu T. Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat 68/69 (2002) 599-609
14. Travers J.B., Huff J.C., Rola-Pleszczynski M., Gelfand E.W., Morelli J.G., and Murphy R.C. Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol 105 6 (1995) 816-823
15. Alappatt C., Johnson C.A., Clay K.L., and Travers J.B. Acute keratinocyte damage stimulates platelet-activating factor production. Arch Dermatol Res 292 5 (2000) 256-259
16. Marathe G.K., Davies S.S., Harrison K.A., et al. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Biol Chem 274 40 (1999) 28395-28404
17. Prescott S.M., Zimmerman G.A., Stafforini D.M., and McIntyre T.M. Platelet-activating factor and related lipid mediators. Ann Rev Biochem 69 (2000) 419-445
18. Goetzl E.J., Derian C.K., Tauber A.I., and Valone F.H. Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents. Biochem Biophys Res Commun 94 3 (1980) 881-888
19. Stremler K.E., Stafforini D.M., Prescott S.M., and McIntyre T.M. Human plasma platelet-activating factor acetylhydrolase Oxidatively fragmented phospholipids as substrates. J Biol Chem 266 17 (1991) 11095-11103
20. Kamido H., Eguchi H., Ikeda H., et al. Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation. J Lipid Res 43 1 (2002) 158-166
21. Travers J.B., Johnson C., Clay K.L., et al. Identification of sn-2 acetyl glycerophosphocholines in human keratinocytes. J Lipid Mediat Cell Signal 16 3 (1997) 139-145
22. Pei Y., Barber L.A., Murphy R.C., et al. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol 161 4 (1998) 1954-1961
23. Dy L.C., Pei Y., and Travers J.B. Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor. J Biol Chem 274 38 (1999) 26917-26921
24. Walterscheid J.P., Ullrich S.E., and Nghiem D.X. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 195 2 (2002) 171-179
25. Marques S.A., Dy L.C., Southall M.D., et al. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J Pharmacol Exp Ther 300 3 (2002) 1026-1035
26. Ishii S., Nagase T., Tashiro F., et al. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J 16 1 (1997) 133-142
27. Barber L.A., Spandau D.F., Rathman S.C., et al. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem 273 30 (1998) 18891-18897
28. Wolf P., Nghiem D.X., Walterscheid J.P., et al. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. Am J Pathol 169 3 (2006) 795-805
29. Shreedhar V., Giese T., Sung V.W., and Ullrich S.E. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 Is responsible for UV-induced systemic immune suppression. J Immunol 160 8 (1998) 3783-3789
30. Zhang Q., Yao Y., Konger R.L., et al. UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system. J Invest Dermatol (2008)
31. Travers J.B., Edenberg H.J., Zhang Q., et al. Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor. J Invest Dermatol 128 2 (2007) 455-460
32. Friedmann P.S., Cooper H.L., and Healy E. Peroxisome proliferator-activated receptors and their relevance to dermatology. Acta Derm Venereol 85 3 (2005) 194-202
33. Michalik L., and Wahli W. Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease. Biochim Biophys Acta 1771 8 (2007) 991-998
34. Issemann I., and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 6294 (1990) 645-650
35. Meirhaeghe A., and Amouyel P. Impact of genetic variation of PPARγ in humans. Mol Gen Metab 83 1/2 (2004) 93-102
36. Kuenzli S., and Saurat J.H. Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol 149 2 (2003) 229-236
37. Ricote M., and Glass C.K. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 1771 8 (2007) 926-935
38. Heikkinen S., Auwerx J., and Argmann C.A. PPARgamma in human and mouse physiology. Biochim Biophys Acta 1771 8 (2007) 999-1013
39. Genolet R., Wahli W., and Michalik L. PPARs as drug targets to modulate inflammatory responses?. Curr Drug Targets-Inflamm Allergy 3 4 (2004) 361-375
40. Szeles L., Torocsik D., and Nagy L. PPARgamma in immunity and inflammation: cell types and diseases. Biochim Biophys Acta 1771 8 (2007) 1014-1030
41. Krishnan A., Nair S.A., and Pillai M.R. Biology of PPAR gamma in cancer: a critical review on existing lacunae. Curr Mol Med 7 6 (2007) 532-540
42. Mao-Qiang M., Fowler A.J., Schmuth M., et al. Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. J Invest Dermatol 123 2 (2004) 305-312
43. Demerjian M., Man M.-Q., Choi E.-H., et al. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model. Exp Dermatol 15 3 (2006) 154-160
44. Kuenzli S., and Saurat J.-H. Peroxisome proliferator-activated receptors as new molecular targets in psoriasis. Cur Drug Targets-Inflamm Allergy 3 2 (2004) 205-211
45. Ellis C.N., Varani J., Fisher G.J., et al. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation. Arch Dermatol 136 5 (2000) 609-616
46. Varani J., Bhagavathula N., Ellis C.N., and Pershadsingh H.A. Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease. Exp Opin Investig Drugs 15 11 (2006) 1453-1468
47. Zhu Y., Alvares K., Huang Q., Rao M.S., and Reddy J.K. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J Biol Chem 268 36 (1993) 26817-26820
48. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270 22 (1995) 12953-12956
49. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 5 (1995) 803-812
50. Kliewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., and Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83 5 (1995) 813-819
51. Rosen E.D., and Spiegelman B.M. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276 41 (2001) 37731-37734
52. Han H., Shin S.-W., Seo C.-Y., et al. 15-Deoxy-delta 12, 14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. Apoptosis 12 11 (2007) 2101-2114
53. Lim H.-J., Lee K.-S., Lee S., et al. 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells. Toxicol Appl Pharmacol 223 1 (2007) 20-27
54. Xiang Z., Lin T., and Reeves S.A. 15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells. J Neuroinflam 4 (2007) 18
55. Zingarelli B., Hake P.W., Mangeshkar P., et al. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt. Shock 28 5 (2007) 554-563
56. Nagy L., Tontonoz P., Alvarez J.G.A., Chen H., and Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93 2 (1998) 229-240
57. Hsi L.C., Wilson L.C., and Eling T.E. Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate alteration in peroxisome proliferator-activated receptor gamma. J Biol Chem 277 43 (2002) 40549-40556
58. Davies S.S., Pontsler A.V., Marathe G.K., et al. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem 276 19 (2001) 16015-16023
59. Zhang Q., Seltmann H., Zouboulis C.C., and Konger R.L. Involvement of PPARgamma in oxidative stress-mediated prostaglandin E (2) production in SZ95 human sebaceous gland cells. J Invest Dermatol 126 1 (2006) 42-48
60. Baker P.R.S., Lin Y., Schopfer F.J., et al. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J Biol Chem 280 51 (2005) 42464-42475
61. Schopfer F.J., Lin Y., Baker P.R.S., et al. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc Natl Acad Sci USA 102 7 (2005) 2340-2345
62. Wright M.M., Schopfer F.J., Baker P.R.S., et al. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc Natl Acad Sci USA 103 11 (2006) 4299-4304
63. Paunel A.N., Dejam A., Thelen S., et al. Enzyme-independent nitric oxide formation during UVA challenge of human skin: characterization, molecular sources, and mechanisms. Free Radic Biol Med 38 5 (2005) 606-615
64. Weller R. Nitric oxide: a key mediator in cutaneous physiology. Clin Exp Dermatol 28 5 (2003) 511-514
65. Meade E.A., McIntyre T.M., Zimmerman G.A., and Prescott S.M. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 274 12 (1999) 8328-8334
66. Chene G., Dubourdeau M., Balard P., et al. n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells. Biochim Biophys Acta 1771 5 (2007) 576-589
67. Kuwamoto K., Miyauchi-Hashimoto H., Tanaka K., et al. Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice. J Invest Dermatol 114 2 (2000) 241-246
68. Chun K.-S., Akunda J.K., and Langenbach R. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors EP2 and EP4. Cancer Res 67 5 (2007) 2015-2021
69. Fischer S.M., Pavone A., Mikulec C., Langenbach R., and Rundhaug J.E. Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis. Mol Carcinogen 46 5 (2007) 363-371
70. Boonstra A., van Oudenaren A., Barendregt B., An L., Leenen P.J.M., and Savelkoul H.F.J. UVB irradiation modulates systemic immune responses by affecting cytokine production of antigen-presenting cells. Int Immunol 12 11 (2000) 1531-1538
71. Kremer I.B., Hilkens C.M., Sylva-Steenland R.M., et al. Reduced IL-12 production by monocytes upon ultraviolet-B irradiation selectively limits activation of T helper-1 cells. J Immunol 157 5 (1996) 1913-1918
72. Bright J.J., Natarajan C., Muthian G., Barak Y., and Evans R.M. Peroxisome proliferator-activated receptor-γ-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis. J Immunol 171 11 (2003) 5743-5750
73. Black H.S. Photocarcinogenesis and diet. Federation Proc 46 5 (1987) 1901-1905
74. Logani M.K., and Davies R.E. Lipid oxidation: biologic effects and antioxidants-a review. Lipids 15 6 (1980) 485-495
75. Bartsch H., and Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg 391 5 (2006) 499-510
76. Indra A.K., Castaneda E., Antal M.C., et al. Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes. J Invest Dermatol 127 5 (2007) 1250-1260
77. Nicol C.J., Yoon M., Ward J.M., et al. PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis. Carcinogen 25 9 (2004) 1747-1755
78. He G., Muga S., Thuillier P., Lubet R.A., and Fischer S.M. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin. Mol Carcinogen 43 4 (2005) 198-206
79. Wondrak G.T., Jacobson M.K., and Jacobson E.L. Identification of quenchers of photoexcited states as novel agents for skin photoprotection. J Pharmacol Exp Ther 312 2 (2005) 482-491
80. Wondrak G.T., Jacobson M.K., and Jacobson E.L. Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem Photobiol Sci 5 2 (2006) 215-237
81. Wan Y., Wang Z., Shao Y., Xu Y., Voorhees J., and Fisher G. UV-induced expression of GADD45 is mediated by an oxidant sensitive pathway in cultured human keratinocytes and in human skin in vivo. Int J Mol Med 6 6 (2000) 683-688
82. Jiang Q., Zhou C., Healey S., et al. UV radiation down-regulates Dsg-2 via Rac/NADPH oxidase-mediated generation of ROS in human lens epithelial cells. Int J Mol Med 18 2 (2006) 381-387
83. Wang H., and Kochevar I.E. Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes. Free Rad Biol Med 38 7 (2005) 890-897
84. Fan C., Katsuyama M., Nishinaka T., and Yabe-Nishimura C. Transactivation of the EGF receptor and a PI3 kinase-ATF-1 pathway is involved in the upregulation of NOX1, a catalytic subunit of NADPH oxidase. FEBS Lett 579 5 (2005) 1301-1305
85. Rezvani H.R., Dedieu S., North S., et al. Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. J Biol Chem 282 22 (2007) 16413-16422
86. Pani G., Bedogni B., Colavitti R., Anzevino R., Borrello S., and Galeotti T. Cell compartmentalization in redox signaling. IUBMB Life 52 1/2 (2001) 7-16
87. Zhao Y., Chaiswing L., Bakthavatchalu V., Oberley T.D., and St Clair D.K. Ras mutation promotes p53 activation and apoptosis of skin keratinocytes. Carcinogen 27 8 (2006) 1692-1698
88. Van Laethem A., Nys K., Van Kelst S., et al. Apoptosis signal regulating kinase-1 connects reactive oxygen species to p38 MAPK-induced mitochondrial apoptosis in UVB-irradiated human keratinocytes. Free Rad Biol Med 41 9 (2006) 1361-1371
89. Gruber F., Oskolkova O., Leitner A., et al. Photooxidation generates biologically active phospholipids that induce heme oxygenase-1 in skin cells. J Biol Chem 282 23 (2007) 16934-16941
90. Pontsler A.V., St Hilaire A., Marathe G.K., Zimmerman G.A., and McIntyre T.M. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein. J Biol Chem 277 15 (2002) 13029-13036
91. Stremler K.E., Stafforini D.M., Prescott S.M., Zimmerman G.A., and McIntyre T.M. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J Biol Chem 264 10 (1989) 5331-5334
92. Stafforini D.M., McIntyre T.M., Zimmerman G.A., and Prescott S.M. Platelet-activating factor acetylhydrolases. J Biol Chem 272 29 (1997) 17895-17898
93. Stafforini D.M., Sheller J.R., Blackwell T.S., et al. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem 281 8 (2006) 4616-4623
94. Lehr H.A., Weyrich A.S., Saetzler R.K., et al. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest 99 10 (1997) 2358-2364
95. Black H.S., Lenger W.A., Gerguis J., and Thornby J.I. Relation of antioxidants and level of dietary lipid to epidermal lipid peroxidation and ultraviolet carcinogenesis. Cancer Res 45 12 Pt 1 (1985) 6254-6259
96. Sharma S.D., Meeran S.M., and Katiyar S.K. Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-κB signaling in in vivo SKH-1 hairless mice. Mol Cancer Ther 6 3 (2007) 995-1005
97. D'Agostini F., Balansky R.M., Camoirano A., and De Flora S. Modulation of light-induced skin tumors by N-acetylcysteine and/or ascorbic acid in hairless mice. Carcinogen 26 3 (2005) 657-664
98. Staniforth V., Chiu L.-T., and Yang N.-S. Caffeic acid suppresses UVB radiation-induced expression of interleukin-10 and activation of mitogen-activated protein kinases in mouse. Carcinogenesis 27 9 (2006) 1803-1811
99. Swindells K., and Rhodes L.E. Influence of oral antioxidants on ultraviolet radiation-induced skin damage in humans. Photodermatol Photoimmunol Photomed 20 (2004) 297-304
100. Mukhtar H. Eat plenty of green leafy vegetables for photoprotection: emerging evidence. J Investig Dermatol 121 2 (2003) viii
101. F'Guyer S., Afaq F., and Mukhtar H. Photochemoprevention of skin cancer by botanical agents. Photodermatol Photoimmunol Photomed 19 2 (2003) 56-72